Clinical Research Directory
Browse clinical research sites, groups, and studies.
Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE
Sponsor: Weill Medical College of Cornell University
Summary
The study team hypothesizes that it is feasible to intraoperatively detect tumor following \[CU64\]DOTATATE injection using the gamma probe device.
Official title: A Pilot Study to Evaluate Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2024-09-11
Completion Date
2027-01
Last Updated
2026-02-27
Healthy Volunteers
No
Conditions
Interventions
Brain Imaging with [Cu64]DOTATATE
Patients will undergo a \[Cu64\]DOTATATE PET/MRI or PET/CT before undergoing radio- guided surgery. Patients will undergo another \[Cu64\]DOTATATE PET/MRI or PET/CT 6 weeks- 3 months after their surgery, and 6 months- 12 months after surgery.
Radio-guided Surgery With Neoprobe Utilization
After the subjects undergo the preoperative \[Cu64\]DOTATATE PET/MRI, subjects will undergo radio-guided surgery in which the surgeon will utilize a standard intraoperative gamma probe (Neoprobe Gamma Detection System ®) to assess primary/residual tumor detection.
Locations (1)
New York-Presbyterian/Weill Cornell Medical Center
New York, New York, United States